z-logo
open-access-imgOpen Access
MO530: Daprodustat is not Associated With an Increased Risk of Cancer: Results From the ASCEND-D and ASCEND-ND Trials
Author(s) -
Ajay Singh,
Christoph Wanner,
Andrzej Jan Wiecek,
Allison Blackorby,
Tara Barker,
Amy M. Meadowcroft,
Alexander R. Cobitz
Publication year - 2022
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfac072.012
Subject(s) - medicine , cancer , erythropoietin , kidney disease , anemia , prostate cancer , clinical trial , population , adverse effect , dialysis , kidney cancer , oncology , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom